On May 20, 2024, Accelerate Diagnostics, Inc. closed the transaction. The company has now issued 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 in the transaction. The company has issued 1,156,069 Units at a price of $1.73 per unit for gross proceeds of $2,700,000.62 in its second and final tranche closing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +0.75% |
|
+3.85% | -65.56% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.56% | 31.88M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust